| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |